- Home
- IMCR vs USA Comparison
IMCR vs USA Comparison
Compare IMCR & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- USA
- Stock Information
- Founded
- IMCR 2008
- USA 1986
- Country
- IMCR United Kingdom
- USA United States
- Employees
- IMCR N/A
- USA N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- USA Finance Companies
- Sector
- IMCR Health Care
- USA Finance
- Exchange
- IMCR Nasdaq
- USA Nasdaq
- Market Cap
- IMCR 1.8B
- USA 1.9B
- IPO Year
- IMCR 2021
- USA N/A
- Fundamental
- Price
- IMCR $33.42
- USA $6.49
- Analyst Decision
- IMCR Buy
- USA
- Analyst Count
- IMCR 8
- USA 0
- Target Price
- IMCR $57.00
- USA N/A
- AVG Volume (30 Days)
- IMCR 288.3K
- USA 880.5K
- Earning Date
- IMCR 11-05-2025
- USA 01-01-0001
- Dividend Yield
- IMCR N/A
- USA 9.66%
- EPS Growth
- IMCR N/A
- USA N/A
- EPS
- IMCR N/A
- USA N/A
- Revenue
- IMCR $356,145,000.00
- USA N/A
- Revenue This Year
- IMCR $29.67
- USA N/A
- Revenue Next Year
- IMCR $11.12
- USA N/A
- P/E Ratio
- IMCR N/A
- USA N/A
- Revenue Growth
- IMCR 26.78
- USA N/A
- 52 Week Low
- IMCR $23.15
- USA $5.62
- 52 Week High
- IMCR $39.33
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- IMCR 44.20
- USA 41.22
- Support Level
- IMCR $35.33
- USA $6.46
- Resistance Level
- IMCR $36.76
- USA $6.60
- Average True Range (ATR)
- IMCR 1.46
- USA 0.07
- MACD
- IMCR -0.12
- USA -0.01
- Stochastic Oscillator
- IMCR 24.65
- USA 16.67
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.